Statements of Stockholders' Equity - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Accumulated Other Comprehensive Income (Loss)	Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2021		59,355,558
Beginning balance at Dec. 31, 2021	$ 733,504	$ 595	$ 1,017,523	$ (1,510)	$ (283,104)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock awards (in shares)		36,500
Issuance of common stock upon exercise of stock awards	731	$ 0	731
Issuance of restricted stock units (in shares)		137,134
Issuance of restricted stock units	0	$ 1	(1)
Comprehensive income (loss)	17,983			(5,611)	23,594
Stock-based compensation	10,805		10,805
Ending balance (in shares) at Mar. 31, 2022		59,529,192
Ending balance at Mar. 31, 2022	763,023	$ 596	1,029,058	(7,121)	(259,510)
Beginning balance (in shares) at Dec. 31, 2022		59,997,713
Beginning balance at Dec. 31, 2022	727,496	$ 601	1,072,132	(6,952)	(338,285)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock awards (in shares)		34,388
Issuance of common stock upon exercise of stock awards	924		924
Issuance of restricted stock units (in shares)		349,499
Issuance of restricted stock units	0	$ 4	(4)
Comprehensive income (loss)	(57,436)			3,327	(60,763)
Stock-based compensation	12,599		12,599
Ending balance (in shares) at Mar. 31, 2023		60,381,600
Ending balance at Mar. 31, 2023	$ 683,583	$ 605	$ 1,085,651	$ (3,625)	$ (399,048)